Dr. David Elliott to Speak at Coronado Biosciences Analyst Event

David Elliott, MD, board-certified in gastroenterology and internal medicine, will be speaking at the April 9 Coronado Biosciences Analyst Event in New York, according to a NASDAQ report.

Advertisement


Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

Coronado Biosciences is a pharmaceutical company that develops biologic treatments for cancer and autoimmune diseases. The April 9 event will feature several physician experts speaking on inflammatory bowel disease, immunology, type 1 diabetes, psoriasis and autism.

Dr. Elliott is the James A. Clifton Chair of Gastroenterology and director of the gastroenterology and hepatology division at the University of Iowa Carver College of Medicine in Iowa City.

More Articles on Gastroenterology:
Apollo Endosurgery Receives CE Mark for Endoscopic Suturing Device
UW Health Opens $21M Digestive Center in Madison
8 Revenue Statistics for GI-Driven ASCs

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.